Vascular Endothelial Growth Factor Receptor-1
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Vascular Endothelial Growth Factor Receptor-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A 180-kDa VEGF receptor found primarily in endothelial cells that is essential for vasculogenesis and vascular maintenance. It is also known as Flt-1 (fms-like tyrosine kinase receptor-1). A soluble, alternatively spliced isoform of the receptor may serve as a binding protein that regulates the availability of various ligands for VEGF receptor binding and signal transduction.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D040281
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D08.811.913.696.620.682.725.400.950.100 D12.776.543.750.630.750.100 D12.776.543.750.750.400.910.100 
						 | 
					
					
						| Concept/Terms | 
						
							Vascular Endothelial Growth Factor Receptor-1- Vascular Endothelial Growth Factor Receptor-1
 - Vascular Endothelial Growth Factor Receptor 1
 - FLT1 Receptor Tyrosine Kinase
 - VEGF Receptor flt-1 Protein
 - VEGF Receptor flt 1 Protein
 - VEGFR-1
 - fms-Like Tyrosine Kinase
 - Tyrosine Kinase, fms-Like
 - Proto-Oncogene Protein flt
 - Proto Oncogene Protein flt
 - FLT1 RTK
 - VEGF Receptor, FLT
 - FLT VEGF Receptor
 - Receptor, FLT VEGF
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Vascular Endothelial Growth Factor Receptor-1".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Vascular Endothelial Growth Factor Receptor-1".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Vascular Endothelial Growth Factor Receptor-1" by people in this website by year, and whether "Vascular Endothelial Growth Factor Receptor-1" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2005 | 0 | 1 | 1 | 
| 2006 | 2 | 0 | 2 | 
| 2007 | 1 | 0 | 1 | 
| 2008 | 0 | 1 | 1 | 
| 2010 | 0 | 1 | 1 | 
| 2012 | 0 | 2 | 2 | 
| 2016 | 1 | 0 | 1 | 
| 2017 | 1 | 0 | 1 | 
| 2019 | 1 | 0 | 1 | 
| 2020 | 1 | 0 | 1 | 
| 2021 | 0 | 1 | 1 | 
| 2022 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Vascular Endothelial Growth Factor Receptor-1" by people in Profiles.
						
					
								- 
								
Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study. J Heart Lung Transplant. 2022 05; 41(5):619-625.
															
								 
							
								- 
								
Effects of modified lipoproteins on human trophoblast cells: a role in pre-eclampsia in pregnancies complicated by diabetes. BMJ Open Diabetes Res Care. 2021 01; 9(1).
															
								 
							
								- 
								
Differential regulation of a placental SAM68 and sFLT1 gene pathway and the relevance to maternal vitamin D sufficiency. Pregnancy Hypertens. 2020 Oct; 22:196-203.
															
								 
							
								- 
								
Computational prediction and in vitro validation of VEGFR1 as a novel protein target for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Sci Rep. 2019 05 02; 9(1):6810.
															
								 
							
								- 
								
Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy. J Steroid Biochem Mol Biol. 2017 10; 173:273-279.
															
								 
							
								- 
								
Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factor. Eur J Immunol. 2016 10; 46(10):2322-2332.
															
								 
							
								- 
								
Alveolar macrophage dynamics in murine lung regeneration. J Cell Physiol. 2012 Sep; 227(9):3208-15.
															
								 
							
								- 
								
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012 May 09; 485(7398):333-8.
															
								 
							
								- 
								
Targeted inhibition of complement activation prevents features of preeclampsia in mice. Kidney Int. 2011 Feb; 79(3):331-9.
															
								 
							
								- 
								
Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia. 2009 Jan; 52(1):160-8.